Rafal Dziadziuszko

Rafal Dziadziuszko

UNVERIFIED PROFILE

Are you Rafal Dziadziuszko?   Register this Author

Register author
Rafal Dziadziuszko

Rafal Dziadziuszko

Publications by authors named "Rafal Dziadziuszko"

Are you Rafal Dziadziuszko?   Register this Author

97Publications

1944Reads

32Profile Views

Short Communication: Management of patients with extensive-stage small-cell lung cancer treated with radiotherapy: A survey of practice.

Cancer Treat Res Commun 2018 30;17:18-22. Epub 2018 Aug 30.

Manchester Cancer Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2018.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333293PMC
May 2019

Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitors.

Cancer Treat Rev 2018 Dec 21;71:59-67. Epub 2018 Oct 21.

Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372183017
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2018.10.011DOI Listing
December 2018

Cardiovascular complications after radiotherapy.

Cardiol J 2018 Oct 19. Epub 2018 Oct 19.

Department of Cardiology, Medical University of Gdansk, Poland.

View Article

Download full-text PDF

Source
https://journals.viamedica.pl/cardiology_journal/article/vie
Publisher Site
http://dx.doi.org/10.5603/CJ.a2018.0120DOI Listing
October 2018

Serum lipid profile discriminates patients with early lung cancer from healthy controls.

Lung Cancer 2017 10 1;112:69-74. Epub 2017 Aug 1.

Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, ul. Wybrzeze Armii Krajowej 15, 44-101 Gliwice, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.07.036DOI Listing
October 2017

MHC class II expression in lung cancer.

Lung Cancer 2017 10 29;112:75-80. Epub 2017 Jul 29.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, 80045, CO, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.07.030DOI Listing
October 2017

Osimertinib - effective treatment of NSCLC with activating mutations after progression on EGFR tyrosine kinase inhibitors.

Contemp Oncol (Pozn) 2017 29;21(3):254-258. Epub 2017 Sep 29.

Department of Oncology and Radiotherapy, Medical University of Gdansk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/wo.2017.70116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701587PMC
September 2017

Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.

N Engl J Med 2017 08 6;377(9):829-838. Epub 2017 Jun 6.

From Lausanne University Hospital, Lausanne (S.P.), and F. Hoffmann-La Roche, Basel (A.Z., E.M., S. Golding, B.B., J.N.) - both in Switzerland; University of Colorado, Denver (D.R.C.); Massachusetts General Hospital, Boston (A.T.S.); University of Michigan, Ann Arbor (S. Gadgeel); Samsung Medical Center, Sungkyunkwan University School of Medicine (J.S.A.), and Seoul National University Hospital (D.-W.K.) - both in Seoul, South Korea; Chao Family Comprehensive Cancer Center, University of California, Irvine, School of Medicine, Orange (S.-H.I.O.); Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France (M.P.); Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland (R.D.); Catalan Institute of Oncology, Barcelona (R.R.); Roche Innovation Center, New York (P.N.M.); and State Key Laboratory of South China, Chinese University of Hong Kong, Hong Kong (T.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1704795DOI Listing
August 2017

LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes.

J Thorac Oncol 2017 05 26;12(5):814-823. Epub 2017 Jan 26.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.01.019DOI Listing
May 2017

PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes.

Med Sci Monit 2017 Mar 9;23:1208-1216. Epub 2017 Mar 9.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356616PMC
http://dx.doi.org/10.12659/msm.899909DOI Listing
March 2017

Pulsed-dose-rate peri-operative brachytherapy as an interstitial boost in organ-sparing treatment of breast cancer.

J Contemp Brachytherapy 2016 Dec 9;8(6):492-496. Epub 2016 Dec 9.

Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/jcb.2016.64512DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241379PMC
December 2016

Whole Brain Radiotherapy for Patients with Non-Small Cell Lung Cancer with EGFR Mutations-Why and When?

J Thorac Oncol 2016 10;11(10):1604-5

Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.08.121DOI Listing
October 2016

Serum mass profile signature as a biomarker of early lung cancer.

Lung Cancer 2016 09 16;99:46-52. Epub 2016 Jun 16.

Medical University of Gdańsk, ul. Dębinki 7, 80-211 Gdańsk, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.06.011DOI Listing
September 2016

An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer.

J Thorac Oncol 2016 08 9;11(8):1273-1281. Epub 2016 Apr 9.

Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, University of Colorado, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961521PMC
August 2016

Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer.

J Thorac Oncol 2015 Jul;10(7):1083-90

*Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Tongji University Institute, Shanghai, People's Republic of China; †Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado; ‡Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland; §Institute of Pathology, University Hospital Cologne, Medical Centre, Cologne, Germany; ‖Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, Colorado; ¶Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, Colorado; and #Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Tongji University Institute, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000562DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467588PMC
July 2015

Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer.

J Thorac Oncol 2015 Jul;10(7):1067-75

*Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina; †Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia; ‡Department of Genetics, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; §Molecular Oncology Laboratory, General University Hospital Research Foundation, Valencia, Spain; ‖Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina; ¶Department of Medicine, University of Chicago, Chicago, Illinois; #Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois; **Department of Thoracic Surgery, and ††Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland; ‡‡Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado; §§Department of Medicine, University of Valencia, Valencia, Spain; ‖‖Department of Oncology, General University Hospital of Valencia, Valencia, Spain; and ¶¶Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000549DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494119PMC
July 2015

Rociletinib in EGFR-mutated non-small-cell lung cancer.

N Engl J Med 2015 Apr;372(18):1700-9

From Massachusetts General Hospital (L.V.S., R.S.H., J.L., Z.P.), Harvard Medical School (L.V.S., G.R.O., R.S.H., Z.P.), and Dana-Farber Cancer Institute (G.R.O.) - all in Boston; the Drug Development Department, Université Paris-Sud, Gustave Roussy Cancer Campus (J.-C.S.), and Institut Gustave Roussy (A.V.), Villejuif - both in France; the David Geffen School of Medicine, University of California, Los Angeles, Los Angeles (J.W.G., E.B.G., M.A.M., S.N.), and Stanford Cancer Institute, Stanford University, Stanford (H.A.W., J.W.N.) - both in California; the Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit (S.M.G., C.G., A.J.W.); University of Texas M.D. Anderson Cancer Center, Houston (V.P.); the Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.J.S.); the Medical University of Gdansk, Gdansk, Poland (R.D.); the University of Colorado (D.L.A., D.R.C.) and University of Colorado Cancer Center (R.C.D.) - both in Aurora; and Clovis Oncology, San Francisco (M.R., C.A.K., S.J.-T., S.L.M., A.R.A.), Boulder, CO (J.I., D.D.), and Cambridge, United Kingdom (L.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1413654DOI Listing
April 2015

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.

J Clin Oncol 2015 Mar 9;33(9):992-9. Epub 2015 Feb 9.

Julien Mazières, Damien Rouvière, and Julie D. Milia, Hôpital Larrey, Centre Hospitalier Universitaire, Université Paul Sabatier; Thomas Filleron, Institut Universitaire du Cancer, Toulouse; Gérard Zalcman, Centre Hospitalier Universitaire, Université de Caen-Basse Normandie, Caen; Pamela Biondani and Benjamin Besse, Gustave Roussy, Villejuif; Fabrice Barlesi, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille; Hervé Léna, Centre Hospitalier Universitaire, Rennes; Isabelle Monnet, Centre Hospitalier Intercommunal de Créteil, Créteil; Luc Thiberville, Centre Hospitalier Universitaire, Rouen; Nicolas Pecuchet, Institut Curie, Paris, France; Lucio Crinò, Medica-Azienda Ospedaliera, Perugia; Federico Cappuzzo, Istituto Toscano Tumori, Ospedale Civile, Livorno, Italy; Anne-Marie C. Dingemans, Maastricht University Medical Center, Maastricht; Egbert F. Smit, VU University Medical Center, Amsterdam, the Netherlands; Sacha I. Rothschild, University Hospital Basel, Medical Oncology, Basel; Christian Spirig, Klinik St Anna; Joachim Diebold and Oliver Gautschi, Cantonal Hospital Luzern, Lucerne, Switzerland; Rafal Dziadziuszko, Gdansk Medical University, Gdansk, Poland; Jurgen Wolf and Roman K. Thomas, Center of Integrated Oncology Köln-Bonn, University Hospital Cologne, University of Cologne; Frauke Leenders and Roman K. Thomas, University of Cologne; Johannes M. Heuckmann, Blackfield AG, Cologne, Germany.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/02/03/JCO.2014.58
Web Search
http://jco.ascopubs.org/content/early/2015/02/03/JCO.2014.58
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.3302
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.3302DOI Listing
March 2015

Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver study.

J Thorac Oncol 2014 Sep;9(9):1354-62

Departments of *Pathology and ††††Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands; †Department of Pathology, Faculty of Medicine, Tsukuba, Japan; ‡Rutgers New Jersey Medical School, Newark, New Jersey; §Department of Pathology, Mount Sinai Medical Center, New York, New York; ‖Elisabeth Brambilla, CHU Albert Michallon, Institut de Biologie, Département d'Anatomie et Cytologie Pathologiques, Grenoble Cedex, France; ¶Brigham and Women's Hospital, Boston, Massachusetts; #Department of Pathology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea; **Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania; ††Piedmont Pathology Associates, Hickory, North Carolina, and University of North Carolina, Chapel Hill, North Carolina; ‡‡Department of Medicine and Pathology, University of Colorado Cancer Center, Aurora, Colorado; §§Division of Pathology, The Cancer Institute, Japanese Foundation Cancer Research, Tokyo, Japan; ‖Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; ¶¶Department of Pathology, CHU A Michallon, INSERM U 823-Institut A Bonniot-University J Fourier, Grenoble, France; ##Department of Pathology, Cancer Center Hospital, Tsukuba, Japan; ***Department of Pathology, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Japan; †††Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York; ‡‡‡Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Tumori, and Università degli Studi of Milan, Milan, Italy; §§§Institut für Pathologie, Jena, Germany; ‖‖‖Duke University Medical Center, Durham, North Carolina; ¶¶¶University of Texas MD Anderson Cancer Center, Houston, Texas; ###Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan; ****Department of Oncology and Radiothe

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000264DOI Listing
September 2014

Early results of a trimodality treatment for superior sulcus tumors.

Kardiochir Torakochirurgia Pol 2014 Sep 28;11(3):268-72. Epub 2014 Sep 28.

Department of Thoracic Surgery, Medical University of Gdansk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/kitp.2014.45675DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283879PMC
September 2014

Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases.

Cancer Treat Rev 2014 Jul 8;40(6):716-22. Epub 2014 Apr 8.

Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2014.03.005DOI Listing
July 2014

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.

Clin Cancer Res 2014 Jun 25;20(12):3299-309. Epub 2014 Apr 25.

Authors' Affiliations: Departments of Medicine, Pathology, Craniofacial Biology, and Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, Colorado; ARIAD Pharmaceuticals, Inc., Cambridge, Massachusetts; Medical University of Gdańsk, Poland; and Department of Prostate Cancer Research, Institute of Pathology, University Hospital of Bonn, Bonn, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062100PMC
June 2014

Miliary brain metastases in a patient with ROS1-rearranged lung adenocarcinoma: a case report.

J Thorac Oncol 2014 May;9(5):e34-6

*Second Department of Radiology, †Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000091DOI Listing
May 2014

Beneath the blood brain barrier: the challenge of diagnosis and management of central nervous system involvement in ALK-positive lung cancer.

J Thorac Oncol 2013 Dec;8(12):1465-6

Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000054DOI Listing
December 2013

Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.

Clin Lung Cancer 2013 Nov 17;14(6):666-673.e2. Epub 2013 Jul 17.

Medical University of Gdansk, Department of Oncology and Radiotherapy, Gdansk, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2013.04.010DOI Listing
November 2013

EGFR inhibitors for wild-type EGFR NSCLC: to use or not to use?

Lancet Oncol 2013 Sep 22;14(10):916-7. Epub 2013 Jul 22.

Department of Oncology and Radiotherapy, Medical University of Gdańsk, 80 211 Gdańsk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70352-8DOI Listing
September 2013

Pulsed dose rate brachytherapy of lip cancer.

J Contemp Brachytherapy 2013 Sep 20;5(3):144-7. Epub 2013 Sep 20.

Department of Oncology and Radiotherapy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/jcb.2013.37777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797410PMC
September 2013

A lack of correlation between mast cells, angiogenesis, and outcome in non-small cell lung cancer.

Exp Lung Res 2012 Aug 30;38(6):281-5. Epub 2012 May 30.

Laboratory of Esthetic Medicine, Medical University of Bialystok, Bialystok, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/01902148.2012.686559DOI Listing
August 2012

Continuous 7-days-a-week external beam irradiation in locally advanced cervical cancer: final results of the Phase I/II study.

Int J Radiat Oncol Biol Phys 2012 Mar 11;82(3):1256-61. Epub 2011 May 11.

Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2010.11.065DOI Listing
March 2012

MicroRNA in lung cancer diagnostics and treatment.

Mutat Res 2011 Dec 20;717(1-2):25-31. Epub 2011 Apr 20.

Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdańsk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mrfmmm.2011.04.002DOI Listing
December 2011

Quantitative immunohistochemistry in lung cancer: clinical perspective.

Folia Histochem Cytobiol 2010 Jan;48(1):7-11

Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2478/v10042-010-0014-2DOI Listing
January 2010

Risk factors for brain relapse in HER2-positive metastatic breast cancer patients.

Breast Cancer Res Treat 2009 Sep 7;117(2):297-303. Epub 2009 Jan 7.

Department of Oncology, Military Institute of Medicine, Warsaw, Ul. Szaserów 128, 00-908 Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-0275-zDOI Listing
September 2009

The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.

Clin Lung Cancer 2009 Jul;10(4):262-72

Developmental Therapeutics Program, University of Colorado Cancer Center, Denver Thoracic Oncology Program, University of Colorado Cancer Center, Denver, Colorado 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2009.n.037DOI Listing
July 2009

The insulin-like growth factor pathway in lung cancer.

J Thorac Oncol 2008 Aug;3(8):815-8

Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31818180f5DOI Listing
August 2008

Advances in genomic and proteomic studies of non-small-cell lung cancer: clinical and translational research perspective.

Clin Lung Cancer 2008 Mar;9(2):78-84

Department of Oncology and Radiotherapy, Medical University of Gdansk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2008.n.012DOI Listing
March 2008

Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case report.

J Thorac Oncol 2007 Jan;2(1):91-2

Department of Medical Oncology, University of Colorado Cancer Center, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
January 2007

Update on epidermal growth factor receptor inhibitor development in lung cancer.

J Thorac Oncol 2006 Sep;1(7):740-3

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
September 2006

Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy.

Clin Cancer Res 2006 Jun;12(12):3652-6

Department of Medicine, University of Colorado Cancer Center and University of Colorado Health Sciences Center, Aurora, 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-0261DOI Listing
June 2006

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

Cancer Res 2006 Jan;66(2):944-50

Department of Medicine/Medical Oncology, University of Colorado Health Sciences Center and University of Colorado Cancer Center, Campus Box 8117, PO Box 6511, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1988DOI Listing
January 2006

Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.

Anticancer Res 2004 Nov-Dec;24(6):4259-63

Department of Biology and Genetics, Medical University of Gdansk, Gdansk, Poland.

View Article

Download full-text PDF

Source
March 2005

[Results of treatment for chronic pleural empyema].

Pneumonol Alergol Pol 2003 ;71(1-2):43-50

View Article

Download full-text PDF

Source
December 2003

The influence of blood transfusion on survival in operated non-small cell lung cancer patients.

J Thorac Cardiovasc Surg 2003 Sep;126(3):755-60

Department of Thoracic Surgery, Medical University of Gdansk, 7 Dêbinki Street, 80-211 Gdansk, Poland.

View Article

Download full-text PDF

Source
September 2003

[The prevalence of serum IgG antibodies against HTLV viruses type I and II in sarcoidosis patients].

Pneumonol Alergol Pol 2002 ;70(1-2):52-7

Katedry i Kliniki Chorób Płuc i Gruźlicy AM w Gdańsku.

View Article

Download full-text PDF

Source
September 2002

Decortication in chronic pleural empyema - effect on lung function.

Eur J Cardiothorac Surg 2002 Mar;21(3):502-7

Department of Thoracic Surgery, Medical University of Gdańsk, Gdańsk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1010-7940(01)01167-8DOI Listing
March 2002